Clinical Trial Update: Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cryoablation combined with sintilimab and lenvatinib for previously treated unresectable liver metastases from solid tumors; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastasis

Drugs mentioned

• Lenvatinib (lenvatinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Liver Metastasis | Phase 2 | Status: RECRUITING